Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Fsd Pharma Inc Subordinate Voting Share (HUGE.CN)

Fsd Pharma Inc Subordinate Voting Share (HUGE.CN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.1250 -0.0200 (-13.79%) 08/14/24 [CNSX]
N/A x N/A N/A x N/A
Post-market 0.1250 unch (unch) -
Quote Overview for Wed, Aug 14th, 2024
Day Low
0.1250
Day High
0.1350
Open 0.1250
Previous Close 0.1450 0.1450
Volume 322,500 322,500
Avg Vol 325,565 325,565
Stochastic %K 12.66% 12.66%
Weighted Alpha -93.07 -93.07
5-Day Change +0.0200 (+19.05%) +0.0200 (+19.05%)
52-Week Range 0.1000 - 2.2300 0.1000 - 2.2300
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 5,758
  • Shares Outstanding, K 709
  • Annual Sales, $ 0 K
  • Annual Income, $ -17,902 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.55
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.35
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -16.25
  • Most Recent Earnings $-3.25 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1000 +25.00%
on 08/08/24
Period Open: 0.2000
0.4950 -74.75%
on 08/09/24
-0.0750 (-37.50%)
since 07/12/24
3-Month
0.1000 +25.00%
on 08/08/24
Period Open: 0.4850
0.5300 -76.42%
on 05/28/24
-0.3600 (-74.23%)
since 05/14/24
52-Week
0.1000 +25.00%
on 08/08/24
Period Open: 1.8800
2.2300 -94.39%
on 09/18/23
-1.7550 (-93.35%)
since 08/14/23

Most Recent Stories

More News
Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates

Awards in favour of Quantum BioPharma Total Approximately $3 Million

QNTM : 4.89 (+8.43%)
QNTM.CN : 6.9500 (+8.59%)
HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)
Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates

Awards in favour of Quantum BioPharma Total Approximately $3 Million

QNTM : 4.89 (+8.43%)
QNTM.CN : 6.9500 (+8.59%)
HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)
Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price

TORONTO, ON / ACCESSWIRE / November 25, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) (the "Company") formerly named FSD Pharma Inc. (Nasdaq:HUGE)(CSE:HUGE) is pleased to follow up on...

QNTM : 4.89 (+8.43%)
QNTM.CN : 6.9500 (+8.59%)
HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)
Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price

TORONTO, ON / ACCESSWIRE / November 25, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) (the "Company") formerly named FSD Pharma Inc. (Nasdaq:HUGE)(CSE:HUGE) is pleased to follow up on...

QNTM : 4.89 (+8.43%)
QNTM.CN : 6.9500 (+8.59%)
HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)
FSD Pharma Completes Name Change to Quantum BioPharma and 65:1 Consolidation - Trading Under New Ticker Symbol "QNTM"

Toronto, Ontario--(Newsfile Corp. - August 15, 2024) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) ("Quantum BioPharma" or the "Company"), formerly FSD Pharma Inc., a biopharmaceutical company dedicated...

HUGE : 5.8435 (-10.10%)
QNTM : 4.89 (+8.43%)
HUGE.CN : 0.1250 (-13.79%)
QNTM.CN : 6.9500 (+8.59%)
FSD Pharma Announces Share Consolidation and Name Change

Toronto, Ontario--(Newsfile Corp. - August 9, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio...

HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)
24/7 Market News Publishes Report Covering Functional Beverage Market, Featuring FSD Pharma

Denver, Colorado--(Newsfile Corp. - July 25, 2024) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, today publishes a news report...

HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)
FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders

Toronto, Ontario--(Newsfile Corp. - July 23, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio...

HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)
24/7 Market News Publishes Report Covering Biotech Developments, Featuring FSD Pharma

Denver, Colorado--(Newsfile Corp. - July 23, 2024) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, today publishes a news report...

HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)
FSD Pharma Files Amended and Restated Material Change Report

Toronto, Ontario--(Newsfile Corp. - July 4, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio...

HUGE : 5.8435 (-10.10%)
HUGE.CN : 0.1250 (-13.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized...

See More

Key Turning Points

3rd Resistance Point 0.1417
2nd Resistance Point 0.1383
1st Resistance Point 0.1317
Last Price 0.1250
1st Support Level 0.1217
2nd Support Level 0.1183
3rd Support Level 0.1117

See More

52-Week High 2.2300
Fibonacci 61.8% 1.4163
Fibonacci 50% 1.1650
Fibonacci 38.2% 0.9137
Last Price 0.1250
52-Week Low 0.1000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals